Page last updated: 2024-08-24

pinacidil pyridine n-oxide and Hypertension

pinacidil pyridine n-oxide has been researched along with Hypertension in 2 studies

*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebisu, H; Eda, M; Fukaya, C; Gohda, M; Hihara, M; Matzno, S; Nakamura, N; Okada, T; Sakashita, H; Takemoto, T1
DeSante, KA; Goldberg, MR; Rockhold, FW; Thompson, WL1

Other Studies

2 other study(ies) available for pinacidil pyridine n-oxide and Hypertension

ArticleYear
Novel potassium channel openers: synthesis and pharmacological evaluation of new N-(substituted-3-pyridyl)-N'-alkylthioureas and related compounds.
    Journal of medicinal chemistry, 1994, Jan-07, Volume: 37, Issue:1

    Topics: 4-Aminopyridine; Amifampridine; Animals; Antihypertensive Agents; Biomechanical Phenomena; Glyburide; Guanidines; Hypertension; Male; Molecular Structure; Norbornanes; Pinacidil; Portal Vein; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Wistar; Structure-Activity Relationship

1994
Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:1

    Topics: Adult; Age Factors; Antihypertensive Agents; Biological Availability; Creatinine; Female; Guanidines; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pinacidil; Potassium Channels

1989